Entry Point Capital, LLC Standard Biotools Inc. Call Options Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LAB
# of Institutions
142Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$135 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$111 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$41.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$32.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$29 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $149M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...